Medicinal product of ATC group L04AC18 with the active substance RISANKIZUMAB - 2012021

World Biggest Tenders Source

This tender with title Medicinal product of ATC group L04AC18 with the active substance RISANKIZUMAB - 2012021 -- Contract Value: 17 960 480,00CZK has been published on Bidding Source portal dated 04 Nov 2026 for the country of Czech Republic. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

Contract Value: 17 960 480,00CZK

General Information

Czech Republic

Tender Title :

Medicinal product of ATC group L04AC18 with the active substance RISANKIZUMAB - 2012021
Contract Value: 17 960 480,00CZK

Tender Type :

Invitation for Bids

Reference No. :

2012021

Country :

Czech Republic

Publish Date :

4 Nov 2026

Closing Date :

1 Dec 2026

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Awarded - Medicinal product with the active ingredient EPOETIN-THETA - 2012028 Czech Republic Awarded - DYNAMIC PURCHASING SYSTEM Drug Supply Using the Flexible Drug Tendering System (FDTS) - 2012016 -- Contract Value: 212 854 396,00CZK Czech Republic COMBINATION OF COAGULATION FACTORS IX, II, VII and X ATC group B02BD01 - 2012025 -- Contract Value: 8 400 000,00CZK Czech Republic Medicinal product of ATC group J05AB16 with the active substance REMDESIVIR - 2012022 -- Contract Value: 13 903 390,00CZK Czech Republic Awarded - Medicinal product with the active ingredient PEMBROLIZUMAB - 2012029 Czech Republic Awarded - Purchase Agreement VZ-2026-000442-03 Parenteral Nutrition for Home Use 2026 - 2012018 -- Contract Value: 20 000 000 000,00CZK Czech Republic Awarded - Medicinal product with the active ingredient TRIMEKAIN-HYDROCHLORIDE - 2012020 Czech Republic Awarded - contract Fresenius 11/2024/073 - 2012043 -- Contract Value: 88 000 000,00CZK Czech Republic Awarded - Medicinal product with the active ingredient PEMIGATINIB - 2012031 Czech Republic Medicinal product of ATC group V08AB05 with the active substance JOPROMID - 2012023 -- Contract Value: 8 299 900,00CZK Czech Republic

Medicinal product of ATC group L04AC18 with the active substance RISANKIZUMAB - 2012021

Contract Value: 17 960 480,00CZK

General Information

Czech Republic

Similar Tenders

Pharmaceutical products Tenders

Czech Republic Tenders

Europe Tenders

Tenders

info@biddingsource.com